Crossix Solutions to Explore Cures for HCP Data Deficiencies at Digital Pharma East
Ira Haimowitz will discuss the traditional challenges of HCP digital measurement and the development of new innovations that can better address marketers’ needs
NEW YORK, NY – September 21, 2017 – Ira Haimowitz, Ph.D., VP, Product Strategy at Crossix, will lead a speaking session at Digital Pharma East on Thursday, October 5, 2017. The conference is being held at the Pennsylvania Convention Center in Philadelphia, PA.
In his presentation, “Curing an HCP Data Deficiency: Measuring the Full Professional Digital Landscape,” Dr. Haimowitz will discuss how the healthcare industry’s approach to HCP marketing has evolved and how to leverage new technology to address existing challenges in HCP digital measurement. Through a detailed case study, he will show how marketers can:
- Measure campaigns across and within publishers
- Determine the HCP specialties reached by publisher
- Ensure that the campaign is reaching the right audiences
- Identify the impact of the campaign through key metrics, such as treatment profile, doctor visitation, and conversion rates
The presentation will begin promptly at 11:40 a.m. ET. For those unable to attend in person, a PDF version of the presentation can be shared upon request.
Those interested in attending Digital Pharma East can use our promo code C856CROSSIX for 15% off registration. For more information about Digital Pharma East, click here. To learn more about our HCP digital measurement capabilities, contact us at email@example.com.
About Ira Haimowitz
Ira Haimowitz, VP, Product Strategy at Crossix, has more than 20 years of pharmaceutical, CPG, agency, and consulting expertise. Ira has shared his knowledge through publishing and speaking opportunities, including authoring the book Healthcare Relationship Marketing. Ira received both his Ph.D. in Computer Science and B.S. degree in Mathematics from MIT.
About Crossix Solutions
Crossix empowers healthcare companies and companies that care about health to plan, measure and optimize their marketing and communication initiatives. Fueled by its Distributed Data Network (DDN) technology and the industry’s most comprehensive set of health and non-health data, which encompasses more than 250 million U.S. consumers, Crossix analytics inform strategic decisions, maximize business results, and drive improved patient outcomes. Crossix connects Rx, OTC, CPG, clinical, medical claims, hospital, consumer and media data with best-in-class privacy safeguards far exceeding HIPAA requirements. Through an unrivaled commitment to innovation and its first-of-their-kind partnerships, Crossix offers an expansive suite of audience and media optimization solutions across programmatic advertising, addressable TV, mobile marketing, search, Point of Care, and beyond. Founded in 2004, Crossix is headquartered in New York City. For more information, visit www.crossix.com.